Lymphoma, Leukemia & Myeloma Congress

Home
United States
New York, NY
Lymphoma, Leukemia & Myeloma Congress

The premier forum for healthcare professionals who study and manage patients with lymphoma, myeloma

For the past sixteen years, L&M has been the premier forum on the latest advances in lymphoma and myeloma. Over forty internationally-recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. The Congress features an interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphatic leukemia, lymphoma and Hodgkin’s disease.

11/24/2025

Behind every impactful meeting is strong scientific leadership.

At the LL&M Winter Symposium, our program is shaped by some of the most respected voices in hematologic malignancies. Experts who live and breathe the science, and who are committed to helping clinicians navigate an ever-changing landscape.

In 2026, our leadership will go beyond the headlines to interpret the data that matters most. Highlighting what’s promising, what’s practice-changing, and how new evidence fits into real-world care.

Through focused sessions and interactive discussions, they’ll guide you through the latest breakthroughs, evolving standards, and what’s on the horizon for the field.

Join us in the new year as we translate cutting-edge research into meaningful impact for patients everywhere. https://hubs.ly/Q03VHGzx0

11/12/2025

Registration for LL&M Great Debates 2026 is now open!

The arguments, the counterpoints, the moments that make you rethink your stance are all returning next year.

Step into the room where hematology’s toughest questions are put to the test and every voice sharpens the discussion.

📅 June 27–28, 2026 | New York City
📅 July 25–26, 2026 | Dallas

Learn more: https://hubs.ly/Q03STNDB0

11/09/2025

During National Nurse Practitioner Week, we honor the NPs who play an essential role in hematology and oncology. We acknowledge and appreciate the way they coordinate care, manage treatment plans, and support patients through every step of their journey.

Your leadership and compassion move care forward. Thank you for everything you do for patients and teams alike.

11/06/2025

The treatment landscape for Richter’s transformation is rapidly evolving, with new data on bispecific antibodies, BTK inhibitors, degraders, and checkpoint inhibitors offering hope for improved outcomes.

At the LL&M Winter Symposium, leading experts will break down the latest evidence on emerging therapies and combination strategies—and discuss what these developments mean for real-world patient care. Join us for the first meeting of 2026: https://hubs.ly/Q03R0L-L0

11/06/2025

The 2026 hematology horizon is overflowing with innovation. From bispecifics and CAR-T therapies to real-world data and immune monitoring, discovery is accelerating and clarity has never been more essential.

Begin the year at the LL&M Winter Symposium, a three-day CME meeting that translates breakthrough hematologic research into practice-ready insights.
Key Focus Areas:
• Bispecifics & T-cell engagers – fixed-duration regimens, MRD as a surrogate, bridging post–CAR-T use.
• CAR-T & novel cellular therapies – faster manufacturing, combination strategies, ctDNA tracking, immune monitoring.

📅 Start 2026 ahead of the curve—where data meets direction, and evidence becomes expertise. Learn more here: https://hubs.ly/Q03S01p_0

$Breaking News: FDA Expands Revumenib Indication in AMLThe FDA has approved revumenib for relapsed or refractory AML with...$

11/02/2025

Breaking News: FDA Expands Revumenib Indication in AML

The FDA has approved revumenib for relapsed or refractory AML with an NPM1 mutation, marking another milestone in targeted menin inhibition.

At the LL&M Winter Symposium, leading experts will break down the latest FDA approvals and discuss how new therapies are transforming treatment strategies and patient care across hematologic malignancies.

January 30 – February 1, 2026
The Ritz Carlton Hotel
Amelia Island, Florida

Learn more here: https://hubs.ly/Q03Q_C3d0

$The FDA has reapproved belantamab mafodotin, reaffirming its potential role in relapsed and refractory multiple myeloma....$

10/29/2025

The FDA has reapproved belantamab mafodotin, reaffirming its potential role in relapsed and refractory multiple myeloma. This decision invites renewed evaluation of sequencing strategies, comparative safety profiles, and the evolving landscape of antibody–drug conjugates.

At the LL&M Winter Symposium, expert faculty will dissect the latest regulatory developments and examine how recent and emerging FDA approvals are shaping treatment sequencing, safety profiles, and real-world decision-making in hematology and oncology.

Join the first hematology/oncology meeting of 2026 for evidence-based discussion and practical application.
January 30 - February 1, 2026
Amelia Island, Florida
https://hubs.ly/Q03QM_sZ0

10/18/2025

Welcome to the inaugural LL&M APP Institute!

We’re thrilled to open this new program created just for advanced practice providers in hematology-oncology. Here’s to learning, connection, and empowering APPs everywhere.

10/17/2025

What a week!

From packed general sessions to hallway conversations and late-breaking data, the 25th Annual LL&M Congress brought together the global hematology community to exchange knowledge, challenge perspectives, and advance care for patients.

A heartfelt thank you to our faculty, attendees, sponsors, and partners for making this milestone year one to remember.

Here’s to 25 years of collaboration and the discoveries still to come!

10/17/2025

What a week of inspiration!

Congratulations to all of this year’s award recipients. Your dedication, discoveries, and leadership continue to move the field forward.

We’re proud to celebrate you and everything you bring to the community.

Address

811 W 7th Avenue
New York, NY

Website

http://www.lymphomaandmyeloma.com/

Alerts

Be the first to know and let us send you an email when Lymphoma, Leukemia & Myeloma Congress posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Magnus Wellness
16 E 40th Street, Fl 4

Want your practice to be the top-listed Clinic in New York?

Our Story

For the past twenty years, L&M has been the premier forum on the latest advances in lymphoma and myeloma. Over forty internationally-recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. The Congress features an interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphatic leukemia, lymphoma and Hodgkin’s disease.

Lymphoma, Leukemia & Myeloma Congress

11/24/2025

11/12/2025

11/09/2025

11/06/2025

11/06/2025

11/02/2025

10/29/2025

10/18/2025

10/17/2025

10/17/2025

Address

Website

Alerts

Shortcuts

Featured

Share

Category

Our Story